<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Nonprescription Drug Product With an Additional Condition for Nonprescription Use</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Nonprescription Drug Product With an Additional Condition for Nonprescription Use</h1>
    <p class="timestamp">Published: 2025-01-27 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) is delayed until March 21, 2025.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Rule</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2025-01840</p>
    <p><strong>Publication Date:</strong> 2025-01-27</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2025/01/27/2025-01840/nonprescription-drug-product-with-an-additional-condition-for-nonprescription-use">https://www.federalregister.gov/documents/2025/01/27/2025-01840/nonprescription-drug-product-with-an-additional-condition-for-nonprescription-use</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2025-01840</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
